Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

HRS Heat Exchangers is helping to support COVID-19 vaccine production: Here’s how

By Sean Whooley | March 18, 2021

Image from HRS Heat Exchangers

Image from HRS Heat Exchangers

HRS Heat Exchangers announced that it received orders for pharmaceutical heat exchangers for use with the manufacturing of COVID-19 vaccines.

Orders were placed by subcontractors working with Pfizer and Moderna, which both have vaccines authorized in the U.S., and Oxford/AstraZeneca, which has been approved across Europe but not yet in the U.S. The orders are set for use in the United Kingdom and in Europe and cover different areas of the vaccine manufacturing process, according to a news release.

HRS SP05 heat exchangers are slated to be used to heat purified water and water for injection (WFI) which is used as make-up water in the vaccine formulation. The heat exchanger series produced by the company has high-quality, pharmaceutical-grade manufacturing and its K Series heat exchangers offer a cleaning-in-place (CIP) solution for cleaning manufacturing equipment between the processing of different batches of the vaccine.

“Because of our range of pharmaceutical heat exchangers we have existing relationships with a number of subcontractors working with the companies producing COVID vaccines, so it was natural that they would look to use proven equipment from a trusted partner as they help their clients expand their production capacities,” HRS international sales & marketing director Matt Hale said in the release. “We are delighted to have played our own, albeit small, part in helping the world manage this pandemic.”


Filed Under: Drug Delivery, Drug Discovery, Drug Discovery and Development, Infectious Disease
Tagged With: AstraZeneca, coronavirus, covid-19, COVID-19 vaccine, HRS Heat Exchangers, Moderna, Pfizer
 

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Related Articles Read More >

A display of DNA sequencing output from an automated ABI 373 sequencer. [National Human Genome Research Institute (NHGRI)]
Helix and Recursion join forces in quest to crack the AI-driven drug discovery code
Ypsomed Ypsodose patch injector
ten23 health to develop large-volume injectables for Ypsomed’s YpsoDose
Shasqi
Click chemistry breakthroughs drive Shasqi and J&J cancer alliance
Shasqi
Nobel-connected startup Shasqi deepens J&J partnership on CAPAC platform
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE